A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient

Yilmaz, Rahmi; Akoglu, HADİM; Yirkpantur, Alper; Kilickap, SAADETTİN; Arici, MUSTAFA; Altun, BÜLENT; AKI, FAZIL; Erdem, YUNUS; Yasavul, Unal; Turgan, Cetin

doi:10.1080/08860220601039528

A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient

Atıf İçin Kopyala

Yilmaz R., Akoglu H., Yirkpantur A., Kilickap S., Arici M., Altun B., ...Daha Fazla

RENAL FAILURE, cilt.29, sa.1, ss.103-105, 2007 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 29 Sayı: 1
Basım Tarihi: 2007
Doi Numarası: 10.1080/08860220601039528
Dergi Adı: RENAL FAILURE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.103-105
Hacettepe Üniversitesi Adresli: Evet

Özet

Renal transplant recipients are susceptible to Kaposi's sarcoma (KS) because of treatment with immunosuppressive drugs. Sirolimus, a new immunosuppressive agent, has been successfully used for immune-suppression in kidney transplant recipients. Several studies have shown the potential role of sirolimus to inhibit progression of KS in kidney-transplant recipients. This report details a kidney-transplant recipient with cutaneous KS who had a complete remission in response to sirolimus therapy.